Charles A Bancroft - Net Worth and Insider Trading

Charles A Bancroft Net Worth

The estimated net worth of Charles A Bancroft is at least $11 Million dollars as of 2024-11-13. Charles A Bancroft is the EVP & CFO of Bristol-Myers Squibb Co and owns about 184,694 shares of Bristol-Myers Squibb Co (BMY) stock worth over $11 Million. Details can be seen in Charles A Bancroft's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Charles A Bancroft has not made any transactions after 2016-05-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Charles A Bancroft

Charles A Bancroft Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Charles A Bancroft owns 3 companies in total, including Kodiak Sciences Inc (KOD) , Bristol-Myers Squibb Co (BMY) , and Colgate-Palmolive Co (CL) .

Click here to see the complete history of Charles A Bancroft’s form 4 insider trades.

Insider Ownership Summary of Charles A Bancroft

Ticker	Comapny	Transaction Date	Type of Owner
KOD	Kodiak Sciences Inc	2020-04-02	director
BMY	Bristol-Myers Squibb Co	2016-05-20	EVP & Chief Financial Officer
CL	Colgate-Palmolive Co	2017-01-01	director

Charles A Bancroft Latest Holdings Summary

Charles A Bancroft currently owns a total of 1 stock. Charles A Bancroft owns 184,694 shares of Bristol-Myers Squibb Co (BMY) as of May 20, 2016, with a value of $11 Million.

Latest Holdings of Charles A Bancroft

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
BMY	Bristol-Myers Squibb Co	2016-05-20	184,694	59.02	10,900,640

Holding Weightings of Charles A Bancroft

Charles A Bancroft Form 4 Trading Tracker

According to the SEC Form 4 filings, Charles A Bancroft has made a total of 0 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years. The most-recent trade in Bristol-Myers Squibb Co is the sale of 30,201 shares on May 20, 2016, which brought Charles A Bancroft around $2 Million.

Insider Trading History of Charles A Bancroft

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Charles A Bancroft Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Charles A Bancroft Ownership Network

Ownership Network List of Charles A Bancroft

No Data

Ownership Network Relation of Charles A Bancroft

Charles A Bancroft Owned Company Details

What does Kodiak Sciences Inc do?

Who are the key executives at Kodiak Sciences Inc?

Charles A Bancroft is the director of Kodiak Sciences Inc. Other key executives at Kodiak Sciences Inc include See Remarks John A. Borgeson , See Remarks Jason Ehrlich , and director & 10 percent owner Baker Bros. Advisors Lp .

Kodiak Sciences Inc (KOD) Insider Trades Summary

Over the past 18 months, Charles A Bancroft made no insider transaction in Kodiak Sciences Inc (KOD). Other recent insider transactions involving Kodiak Sciences Inc (KOD) include a net sale of 8,629 shares made by John A. Borgeson , and a net sale of 3,390 shares made by Jason Ehrlich .

In summary, during the past 3 months, insiders sold 0 shares of Kodiak Sciences Inc (KOD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 12,019 shares of Kodiak Sciences Inc (KOD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 12,019 shares.

Kodiak Sciences Inc (KOD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kodiak Sciences Inc Insider Transactions

No Available Data

What does Bristol-Myers Squibb Co do?

Who are the key executives at Bristol-Myers Squibb Co?

Charles A Bancroft is the EVP & Chief Financial Officer of Bristol-Myers Squibb Co. Other key executives at Bristol-Myers Squibb Co include Chief Medical Offr. & Drug Dev. Samit Hirawat , EVP & Chief Commercial Officer Christopher S. Boerner , and EVP & Corporate Affairs Cari Gallman .

Bristol-Myers Squibb Co (BMY) Insider Trades Summary

Over the past 18 months, Charles A Bancroft made no insider transaction in Bristol-Myers Squibb Co (BMY). Other recent insider transactions involving Bristol-Myers Squibb Co (BMY) include a net purchase of 5,071 shares made by Christopher S. Boerner , a net sale of 17,986 shares made by Ann Powell Judge , and a net purchase of 8,500 shares made by Samuels Theodore R. Ii .

In summary, during the past 3 months, insiders sold 700 shares of Bristol-Myers Squibb Co (BMY) in total and bought 1,830 shares, with a net purchase of 1,130 shares. During the past 18 months, 19,418 shares of Bristol-Myers Squibb Co (BMY) were sold and 15,401 shares were bought by its insiders, resulting in a net sale of 4,017 shares.

Bristol-Myers Squibb Co (BMY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Bristol-Myers Squibb Co Insider Transactions

No Available Data

What does Colgate-Palmolive Co do?

Who are the key executives at Colgate-Palmolive Co?

Charles A Bancroft is the director of Colgate-Palmolive Co. Other key executives at Colgate-Palmolive Co include Chief Financial Officer Sutula Stanley J Iii , Pres. & Colgate-Africa/Eurasia Panagiotis Tsourapas , and CLO and Secretary Jennifer Daniels .

Colgate-Palmolive Co (CL) Insider Trades Summary

Over the past 18 months, Charles A Bancroft made no insider transaction in Colgate-Palmolive Co (CL). Other recent insider transactions involving Colgate-Palmolive Co (CL) include a net sale of 121,826 shares made by Panagiotis Tsourapas , a net sale of 106,785 shares made by Jennifer Daniels , and a net sale of 73,978 shares made by John W Kooyman .

In summary, during the past 3 months, insiders sold 117,755 shares of Colgate-Palmolive Co (CL) in total and bought 0 shares, with a net sale of 117,755 shares. During the past 18 months, 688,822 shares of Colgate-Palmolive Co (CL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 688,822 shares.

Colgate-Palmolive Co (CL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Colgate-Palmolive Co Insider Transactions

No Available Data

Charles A Bancroft Mailing Address

Above is the net worth, insider trading, and ownership report for Charles A Bancroft. You might contact Charles A Bancroft via mailing address: Bristol-myers Squibb Company, Route 206 & Province Line Road, Princeton Nj 08543.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.